Federal Right-To-Try Law Allows Patients to Access Experimental Medicines

January 30, 2019 Media Mentions

On January 30, Bloomberg Law published an article entitled, "Medical Centers Need Policies for Right-to-Try Oversight," discussing how a federal experimental medicines access law, meant to get around FDA regulations, gives patients with life threatening conditions opportunities to try unapproved drugs. Verrill Dana Health Care & Life Sciences attorney Kate Heffernan explains how the law, more commonly known as the right-to-try, also does not discuss how institutions' oversight functions factor into the process.

To learn more and hear Kate's thoughts, visit Bloomberg Law's website here.

Contact Verrill at (855) 307 0700